Loading page content…
Loading page content…
NHS England · UKI
Value
£160,000,000 (awarded)
First notice
17 Oct 2025
Latest notice
7 Apr 2026
OCID
ocds-h6vhtk-05cf3b
Coloured steps have been published. Click any step to jump to that notice.
All 5 notices for this procurement, oldest first.
NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
Contract award
Contract performance
Contract change
Contract termination
Procurement termination